Answers are grounded in this paper and cite their sources.
Patients with liver cirrhosis are known to have increased risk of bleeding particularly from gastrointestinal tract.However, recent literature has shown that patients with liver cirrhosis are also at increased risk of thrombotic complications.Therefore, it is important to consider anticoagulation in cirrhotic patients.The purpose of this article is to review the epidemiological studies available in scientific literature comparing the risk of bleeding in cirrhotic patients utilizing DOACs vs traditional anticoagulation.
No takes yet. Share an insight, caveat, or question.
Saad Qadwai (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: